These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6952964)

  • 21. The podophyllotoxin derivatives VP16-213 and VM26.
    Issell BF
    Cancer Chemother Pharmacol; 1982; 7(2-3):73-80. PubMed ID: 7044593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of VM 26 (epipodophyllotoxin) in treating acute leukemias and lymphomas in the adult].
    Kondrat'eva NA; Gershanovich ML; Kondrat'ev VB; Lebedev VN; Vygovskaia IaI
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):10-4. PubMed ID: 7279889
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial.
    Rodman JH; Abromowitch M; Sinkule JA; Hayes FA; Rivera GK; Evans WE
    J Clin Oncol; 1987 Jul; 5(7):1007-14. PubMed ID: 3598607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment strategies in relation to drug action.
    Muggia FM; McVie G
    NCI Monogr; 1987; (4):129-33. PubMed ID: 2819724
    [No Abstract]   [Full Text] [Related]  

  • 25. [The toxicity of massive dosis of VM26 (4-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside). A contribution to the therapy of advanced ovarian cancer (author's transl)].
    Jankowski RP; Vahrson H
    Med Klin; 1977 Dec; 72(49):2122-6. PubMed ID: 337083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults].
    Marín P; Grañena A; Carreras E; Sierra J; Olivé MT; Rozman C
    Sangre (Barc); 1984; 29(4-A):399-404. PubMed ID: 6594782
    [No Abstract]   [Full Text] [Related]  

  • 27. The epipodophyllotoxin teniposide in therapy for childhood acute lymphocytic leukemia.
    Rivera GK
    J Clin Oncol; 1988 Feb; 6(2):191-3. PubMed ID: 3276820
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
    Radice PA; Bunn PA; Ihde DC
    Cancer Treat Rep; 1979 Aug; 63(8):1231-9. PubMed ID: 225026
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current therapy of malignant blood diseases].
    de Werra P
    Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the use of teniposide and vincristine in combination chemotherapy for non-Hodgkin's lymphoma.
    Cancer Treat Rep; 1982 Jan; 66(1):49-55. PubMed ID: 7053265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teniposide in recurrent or advanced cervical carcinoma: a phase II trial in patients not previously treated with cytotoxic therapy.
    Pfeiffer P; Cold S; Bertelsen K; Panduro J; Sandberg E; Rose C
    Gynecol Oncol; 1990 May; 37(2):230-3. PubMed ID: 2344968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teniposide in epithelial ovarian carcinoma: a phase II trial of the Gynecologic Oncology Group.
    Muss H; Bundy BN; DiSaia PJ; Twiggs LB
    Cancer Treat Rep; 1986 Oct; 70(10):1231-2. PubMed ID: 3530450
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of acute leukemia and malignant lymphoma with (2"R)-4'-O-tetrahydropyranyladriamycin.
    Ohno R; Kimura K; Amaki I; Hirano M; Hoshino A; Ikeda Y; Kimura I; Kobayashi M; Konno K; Majima H
    Cancer Chemother Pharmacol; 1987; 20(3):230-4. PubMed ID: 3315282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of preparation VM 26 (epipodophyllotoxin) for treating lymphomas in children and adults].
    Kondrat'eva NA; Gershanovich ML; Kondrat'ev VB; Lebedev VN; Vialushkin VIa
    Vopr Onkol; 1981; 27(4):82-7. PubMed ID: 7015693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose teniposide for refractory malignancies: a phase I study.
    de Vries EG; Mulder NH; Postmus PE; Vriesendorp R; Willemse PH; Sleijfer DT
    Cancer Treat Rep; 1986 May; 70(5):595-8. PubMed ID: 3708608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenal steroids in the treatment of malignant hematologic disease.
    Cline MJ
    Med Clin North Am; 1973 Sep; 57(5):1203-9. PubMed ID: 4205834
    [No Abstract]   [Full Text] [Related]  

  • 37. The epipodophyllotoxin derivatives VM-26 and VP-16-213, 1976-1979, a review.
    Nissen NI; Dombernowsky P; Hansen HH; Pedersen AG
    Recent Results Cancer Res; 1980; 74():98-106. PubMed ID: 7003663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular toxic effects of VM26 in the treatment of acute lymphatic leukemia. Presentation of two cases.
    Razon-Veronesi S
    Tumori; 1982 Jun; 68(3):253-5. PubMed ID: 6958114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases.
    Grem JL; Hoth DF; Leyland-Jones B; King SA; Ungerleider RS; Wittes RE
    J Clin Oncol; 1988 Feb; 6(2):351-79. PubMed ID: 3276827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of teniposide in small cell carcinoma of the lung.
    Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.